SPC
SER icon

Sigma Planning Corp’s Serina Therapeutics SER Stock Holding History

Sigma Planning Corp’s Portfolio SER Stock Details SER Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-8,144
Closed -$110K – 1255
2023
Q4 		$110K Buy
8,144
+2,987
+58% +$55K 0.01% 806
2023
Q3 		$123K Buy
5,157
+1,185
+30% +$31.3K ﹤0.01% 1130
2023
Q2 		$125K Buy
3,972
+242
+6% +$5.18K ﹤0.01% 1138
2023
Q1 		$87K Sell
3,730
-108
-3% -$2.48K ﹤0.01% 1244
2022
Q4 		$74.5K Buy
3,838
+506
+15% +$10.7K ﹤0.01% 1212
2022
Q3 		$66K Buy
3,332
+15
+0.5% +$339 ﹤0.01% 1208
2022
Q2 		$67K Buy
3,317
+825
+33% +$22.3K ﹤0.01% 1235
2022
Q1 		$75K Sell
2,492
-16
-0.6% -$455 ﹤0.01% 1321
2021
Q4 		$96K Hold
2,508
– – ﹤0.01% 1329
2021
Q3 		$83K Buy
2,508
+1,038
+71% +$43.5K ﹤0.01% 1328
2021
Q2 		$80K Buy
1,470
+802
+120% +$40.2K ﹤0.01% 1372
2021
Q1 		$38K Buy
668
+94
+16% +$6.58K ﹤0.01% 1317
2020
Q4 		$31K Buy
574
+100
+21% +$5.76K ﹤0.01% 1181
2020
Q3 		$14K Buy
474
+57
+14% +$2.03K ﹤0.01% 1054
2020
Q2 		$14K Sell
417
-28
-6% -$824 ﹤0.01% 1050
2020
Q1 		$15K Sell
445
-657
-60% -$30.9K ﹤0.01% 902
2019
Q4 		$71K Sell
1,102
-51
-4% -$2.75K ﹤0.01% 1021
2019
Q3 		$79K Sell
1,153
-55
-5% -$5.22K ﹤0.01% 961
2019
Q2 		$156K Buy
1,208
+234
+24% +$31.7K 0.01% 935
2019
Q1 		$139K Buy
+974
New +$142K 0.01% 883

Other funds holding SER

BC
Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
RAM
Riggs Asset Management Dallas, Pennsylvania $486M AUM 59.08% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AFG
Albion Financial Group Salt Lake City, Utah $1.73B AUM 20.99% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Sigma Planning Corp's SER Position: Q1 2024 in Review

Sigma Planning Corp sold out of Serina Therapeutics (SER) in Q1 2024, closing a stake of 8,144 shares — an estimated $110K sold.

Sigma Planning Corp first reported a position in SER in Q1 2019 and held it in 20 quarters. The position peaked at $156K in Q2 2019. 13 funds tracked by Wall St. Rank hold SER as of Q1 2024.

  • Sigma Planning Corp reported no remaining Serina Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Sigma Planning Corp sold 8,144 Serina Therapeutics shares in Q1 2024, an estimated $110K.
  • Sigma Planning Corp first reported a position in Serina Therapeutics in Q1 2019 and held it in 20 quarters.
  • Sigma Planning Corp's Serina Therapeutics position peaked at $156K in Q2 2019.
  • 13 funds tracked by Wall St. Rank held Serina Therapeutics as of Q1 2024.

Based on Sigma Planning Corp's 13F filing for Q1 2024, filed 2 May 2024.